Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Hardcover)


The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

R3,020

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles30200
Mobicred@R283pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days



Product Description

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Productivity Press

Country of origin

United States

Series

Chapman & Hall/CRC Biostatistics Series

Release date

December 2016

Availability

Expected to ship within 12 - 17 working days

First published

2017

Authors

Dimensions

234 x 156 x 27mm (L x W x T)

Format

Hardcover - Cloth over boards

Pages

386

ISBN-13

978-1-4987-0415-1

Barcode

9781498704151

Categories

LSN

1-4987-0415-8



Trending On Loot